Predictors for Survival and Good Neurological Outcome in E-CPR and Non CPR Treated Patients

Launched by SAHLGRENSKA UNIVERSITY HOSPITAL · Dec 12, 2019

Keywords

ClinConnect Summary

This clinical trial is looking at ways to improve the care for patients who have experienced a cardiac arrest and have undergone a special treatment called Extracorporeal Membrane Oxygenation (ECMO). The researchers want to find out how to better choose which patients will benefit the most from this treatment, as only a few survive and many suffer from brain injuries. They will also be examining the effectiveness of a new setup for ECMO that could help reduce the time patients spend without circulation, which is crucial for better outcomes. Additionally, the study aims to understand how well patients do in the long run, both mentally and emotionally, after receiving ECMO, and to identify any challenges they may face in their daily lives.

If you or someone you know is a patient receiving ECMO treatment at Sahlgrenska University Hospital, you may be eligible to participate in this trial. There are no specific exclusions, so anyone treated with ECMO can take part. Participants can expect to undergo evaluations that will help determine their neurological health and life satisfaction over the next ten years. This research hopes to create a better future for patients who have suffered cardiac arrest, ensuring they receive the best possible care and support.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • ECMO-treated patients att Sahlgrenska University Hospital
• Exclusion Criteria:
• • None